CA2015377A1 - Autoanticorps qui augmentent la vitesse d'une reaction chimique - Google Patents

Autoanticorps qui augmentent la vitesse d'une reaction chimique

Info

Publication number
CA2015377A1
CA2015377A1 CA2015377A CA2015377A CA2015377A1 CA 2015377 A1 CA2015377 A1 CA 2015377A1 CA 2015377 A CA2015377 A CA 2015377A CA 2015377 A CA2015377 A CA 2015377A CA 2015377 A1 CA2015377 A1 CA 2015377A1
Authority
CA
Canada
Prior art keywords
autoantibodies
enhance
rate
chemical reaction
ala18
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2015377A
Other languages
English (en)
Other versions
CA2015377C (fr
Inventor
Sudhir Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IGEN Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2015377A1 publication Critical patent/CA2015377A1/fr
Application granted granted Critical
Publication of CA2015377C publication Critical patent/CA2015377C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Road Signs Or Road Markings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002015377A 1989-04-25 1990-04-25 Autoanticorps qui augmentent la vitesse d'une reaction chimique Expired - Fee Related CA2015377C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/343,081 1989-04-25
US07/343,081 US5236836A (en) 1989-04-25 1989-04-25 Autoantibodies which enhance the rate of a chemical reaction

Publications (2)

Publication Number Publication Date
CA2015377A1 true CA2015377A1 (fr) 1990-10-25
CA2015377C CA2015377C (fr) 2000-07-25

Family

ID=23344622

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002015377A Expired - Fee Related CA2015377C (fr) 1989-04-25 1990-04-25 Autoanticorps qui augmentent la vitesse d'une reaction chimique

Country Status (12)

Country Link
US (1) US5236836A (fr)
EP (1) EP0469060B1 (fr)
JP (1) JPH04504664A (fr)
AT (1) ATE140958T1 (fr)
AU (1) AU643437B2 (fr)
CA (1) CA2015377C (fr)
DE (1) DE69027988T2 (fr)
DK (1) DK0469060T3 (fr)
ES (1) ES2092508T3 (fr)
IL (1) IL94201A (fr)
WO (1) WO1990013661A1 (fr)
ZA (1) ZA903109B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229272A (en) * 1989-04-25 1993-07-20 Igen, Inc. Catalytic antibody components
ZA893284B (en) * 1988-05-04 1990-03-28 Igen Inc Peptide analogs and their use as haptens to elicit catalytic antibodies
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies
US5318897A (en) * 1989-04-25 1994-06-07 Igen, Inc. Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
JP3691846B2 (ja) * 1992-03-16 2005-09-07 ナサニール ホールスタッター，ヤコブ 選択方法
US20030099945A1 (en) * 1994-09-20 2003-05-29 Invenux, Inc. Parallel selex
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
US20030044420A1 (en) * 1999-09-24 2003-03-06 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
US20050084488A1 (en) * 2003-04-10 2005-04-21 Mulkerrin Michael G. Asparagine deaminase catalytic antibodies
GB2420850A (en) * 2004-12-03 2006-06-07 Orion Diagnostica Oy Particle based binding assay
JP6488520B2 (ja) 2013-08-20 2019-03-27 国立研究開発法人科学技術振興機構 ヒト抗体κ型軽鎖複合体含有組成物及びその製造方法
WO2019175767A1 (fr) * 2018-03-12 2019-09-19 Smartfreez, Lda Appareil et procédé de mesure de la cinétique de dégradation d'un biomatériau en solution aqueuse au-dessous de la température de congélation normale

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4492751A (en) * 1978-04-10 1985-01-08 Miles Laboratories, Inc. Heterogenous specific binding assay employing an enzyme substrate as label
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4493890A (en) * 1981-03-23 1985-01-15 Miles Laboratories, Inc. Activated apoglucose oxidase and its use in specific binding assays
US4661586A (en) * 1981-11-17 1987-04-28 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal anti-idiotype antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JP2540508B2 (ja) * 1983-11-29 1996-10-02 イージエン・インコーポレイテッド 化学反応を触媒する方法
US4659567A (en) * 1984-09-07 1987-04-21 Scripps Clinic & Research Foundation Molecules with antibody combining sites that bind to hydrolytic transition states
US5030717A (en) * 1986-09-17 1991-07-09 Scripps Clinic And Research Foundation Antibodies which catalyze hydrolysis of ester bonds
EP0222876A1 (fr) * 1985-05-07 1987-05-27 California Biotechnology, Inc. Proteine fusionnee pour des systemes d'essais immunologiques a enzymes
US4792446A (en) * 1986-06-23 1988-12-20 Igen, Inc. Production of antibody catalysts
US4963355A (en) * 1986-06-23 1990-10-16 Igen, Inc. Production of antibody catalysts
US4900674A (en) * 1987-05-28 1990-02-13 Scripps Clinic And Research Foundation Antibody combining sites that exhibit amide or ester synthase activity
ZA893284B (en) * 1988-05-04 1990-03-28 Igen Inc Peptide analogs and their use as haptens to elicit catalytic antibodies
ZA896408B (en) * 1988-08-26 1991-05-29 Igen Inc Method of catalyzing stereochemical reactions
AU634186B2 (en) * 1988-11-11 1993-02-18 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
US5215889A (en) * 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies

Also Published As

Publication number Publication date
ZA903109B (en) 1991-11-27
AU5646890A (en) 1990-11-29
EP0469060A4 (en) 1992-06-03
EP0469060B1 (fr) 1996-07-31
US5236836A (en) 1993-08-17
CA2015377C (fr) 2000-07-25
DE69027988T2 (de) 1997-01-09
IL94201A0 (en) 1991-01-31
IL94201A (en) 1995-07-31
AU643437B2 (en) 1993-11-18
WO1990013661A1 (fr) 1990-11-15
JPH04504664A (ja) 1992-08-20
DE69027988D1 (de) 1996-09-05
EP0469060A1 (fr) 1992-02-05
ES2092508T3 (es) 1996-12-01
ATE140958T1 (de) 1996-08-15
DK0469060T3 (da) 1996-12-23

Similar Documents

Publication Publication Date Title
CA2015377A1 (fr) Autoanticorps qui augmentent la vitesse d'une reaction chimique
EP0387231A3 (fr) Inhibiteurs des protéases rétro-virales
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
IE811785L (en) Polypeptides
AU4005295A (en) Compositions for the delivery of antigens
CA2177827A1 (fr) Nouvelles proteines modulant l'apoptose, adn codant pour ces proteines, et leur mode d'utilisation
CA2189427A1 (fr) Variants de subtilisine 309 a adsorption reduite et a hydrolyse accrue
CA2137378A1 (fr) Compositions de d-enzyme et methodes d'utilisation
CA2206008A1 (fr) Methode pour la synthese d'analogues de la parathormone et de peptide apparente a la parathormone
CA2214579A1 (fr) Variants de la subtilisine dy dotes d'un pouvoir d'adsorption affaibli et d'une capacite d'hydrolyse accrue
EP0498784A3 (en) Inhibitors of retroviral protease
CA2238296A1 (fr) Genes de proteases ultrathermostables
WO1988002374A3 (fr) Peptides inhibiteurs de la rennine presentant des parties nouvelles a terminaison en c
WO1998042827A3 (fr) Gene codant pour un oxalate decarboxylase isole a partir d'aspergillus phoenices
WO1987005909A3 (fr) Inhibiteurs de la renine ayant un pseudo dipeptide de lactame
EP0333587A3 (fr) Méthode pour purifier et isoler les peptides carboxyterminaux
EP0844252A3 (fr) Peptides cycliques ayant une extrémité destinée à un couplage chimique ultérieur et leurs procédés de préparation
IL97333A (en) Inhibitors which inhibit catalytic auto-antibodies from catalyzing the cleavage of peptide bonds in substrates and methods of preparation of said inhibitors
WO1997039029A3 (fr) Epitope antigenique du determinant a de l'antigene de surface de l'hepatite b et ses utilisations
EP1022332A4 (fr) Beta-fructofuranosidase et gene correspondant
AU7809591A (en) Novel enzyme and dna coding therefor
NZ320932A (en) Short forms of chemokine b-8
CA2197651A1 (fr) Or-1, recepteur orphelin appartenant a la famille des recepteurs nucleaires
AU3524993A (en) Method of peptide synthesis and new synthesis intermediates
MX9702515A (es) Biosensor con biomaterial covalentemente fijado a una superficie de señal activa.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed